Keyora Female Chrono-Nutrition EP-32: The Bone – Vascular – Metabolic Execution Matrix: Postmenopausal Bone Remodeling, Endothelial Delivery, Metabolic Flexibility, Mitochondrial ATP Readiness, and Long-Term Tissue Function A Structured Clinical Human-Evidence Review of Soy Isoflavones and Phenotype-Matched CoQ10, Astaxanthin, Phospholipid Omega-3, and Formula-Specific Nutrient Support DOI: 10.13140/RG.2.2.14132.41604
Keyora Female Chrono-Nutrition EP-31: The Menstrual Pain – Neurovascular Interface: Primary Dysmenorrhea, Menstrual Migraine, Mixed Pain Amplification, and Secondary Pain Differentiation Establishing The Evidence-Supported Effectiveness of Keyora Multi-Nutrient Intervention Through Human Trials and Prospective Outcome Measurement DOI: 10.13140/RG.2.2.29585.80487
Keyora Female Chrono-Nutrition EP-30: The PCOS Phenotype Multi-Nutrient Re-Synchronization Matrix: Insulin Resistance, Hyperandrogenism, Ovulatory Dysfunction, Stress-Sleep Amplification, and Ovarian Redox-Metabolic Burden A Clinical Human-Evidence Review of Soy Isoflavones, Conditional Vitex, CoQ10, Astaxanthin, and Phospholipid Omega-3 DOI: 10.13140/RG.2.2.18067.85281
Keyora Female Chrono-Nutrition EP-29: The Dopamine–Prolactin–Luteal Feedback Continuity Matrix – Cyclic Mastalgia, Premenstrual Spotting, Cycle Variability, Late-Luteal Symptom Recurrence, and Post-Ovulatory Endocrine Readability A Clinical Human-Evidence Review of Multi-Nutrient Intervention Integrating Vitex, Soy Isoflavones, MoodFlow, Co-Q10, Astaxanthin, and Phospholipid-Bound Omega-3 DOI: 10.13140/RG.2.2.16010.02240
Keyora Female Chrono-Nutrition EP-28: The Keyora PMS / PMDD Multi-Axis Intervention Matrix: Integrating Vitex and Soy Isoflavones Across Late-Luteal Timing, Ovarian-Steroid Sensitivity, Neuro-Circadian Fragility, Stress Reactivity, Fatigue, Inflammation, and Physical Symptom Burden Integrating MoodFlow 8 in 1, Co-Q10 17 in 1, Asta 16MG, and Antarctic Krill Oil Through Distinct Neuro-Circadian, Micronutrient-Energy, Redox–Fatty-Acid, and Phospholipid Omega-3 Pathways DOI: 10.13140/RG.2.2.11429.05608
Keyora Female Chrono-Nutrition EP-27: Soy Isoflavones and The Menopausal Multi-Nutrient Re-Synchronization Matrix: From ER-β Receptor Context and Residual Cycle Readability to Vasomotor, Neuro-Circadian, ATP–Redox, and Phospholipid–Membrane Execution A Phenotype-First Framework for Conditional Vitex and Pathway-Matched MoodFlow, Co-Q10, Astaxanthin, and Antarctic Krill Oil DOI: 10.13140/RG.2.2.12464.52480
Keyora Female Chrono-Nutrition EP-26: Vitex and The Extract-Dose-Endpoint Trust Algorithm: Preparation Specificity, Dose Isomorphism, Label Transparency, Safety Boundaries, and Evidence-Grade Product Choice Why Chaste Tree Berry Products Must Be Judged By The Extract Actually Used, The Dose Actually Delivered, The Endpoint Actually Studied, and The Claims The Evidence Can Defend DOI: 10.13140/RG.2.2.22399.16806
Keyora Female Chrono-Nutrition EP-25: Vitex and The Preconception Endocrine-Feedback Continuity Gate: Active Trying, Cycle-to-Cycle Symptom Response, Pattern Persistence, Fertility-Evaluation Escalation, and Pregnancy-Aware Transition Why Chaste Tree Berry Retains Clear Intervention Relevance Only While The Original Vitex-Fit Rhythm Pattern Remains Visible - and How Meaningful Improvement, Lost Fit, Possible Pregnancy, or A Higher-Priority Clinical Question Should Redirect The Decision DOI: 10.13140/RG.2.2.18670.16962
Keyora Female Chrono-Nutrition EP-24: Vitex Before Pregnancy Planning: Why Cycle Rhythm, PMS, Breast Tenderness, Spotting, and Stress Sensitivity Matter Before Conception A Vitex-Centered Preconception Framework For Women Who Want Better Rhythm Readiness Without Fertility, Ovulation-Restoration, Or Pregnancy-Rate Claims DOI: 10.13140/RG.2.2.29578.63682
Keyora Female Chrono-Nutrition EP-23: Vitex and The Irregular Cycle Rhythm Gate: Cycle-Length Variability, Premenstrual Spotting, HPG Rhythm, Dopamine-Prolactin Communication, and Cycle Predictability Why Chaste Tree Berry Becomes Clinically Relevant When Menstrual Timing Becomes Unpredictable Through Pituitary Feedback, Luteal Context, Clinical Exclusion Boundaries, and Evidence-Bounded Cycle Interpretation DOI: 10.13140/RG.2.2.35732.46727
